Acumen Pharmaceuticals, Inc. (ABOS) stock has reached a new 52-week low, trading at $1.31 USD, as investors navigate a turbulent market environment. This latest price point reflects a significant ...
1don MSN
Gain insights into Albemarle's Q4 2024 earnings call: cost reductions, lithium pricing strategies, CAPEX cuts, and projections for 2025 cash flow ...
Find the latest Acumen Pharmaceuticals, Inc. ABOS analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback